On July 10, a live round-table discussion was held – “Cardiovascular Disease: A New Perspective in a Pandemic” – to address the problems of chronic cardiovascular diseases. Director General of Almazov Centre Evgeny Shlyakhto attended the event.
In his presentation, Prof. Shlyakhto described the situation with cardiology care for patients with cardiovascular diseases and specifically with the chronic course of the disease.
“Cardiovascular disease is a leading cause of mortality, including in the working age population. Patients with chronic heart failure need constant monitoring of their health and should have access to the necessary medical care and all necessary precautions should be taken in the context of a coronavirus infection pandemic,” highlighted Evgeny Shlyakhto.
Director General of Almazov Centre spoke about the development of new approaches to the diagnosis and treatment of patients with chronic cardiovascular disease, including the availability of innovative drugs, as well as the measures taken to improve the patient routing and the system continuity between inpatient and outpatient care.
According to Prof. Shlyakhto, promising areas for improving medical care in terms of chronic cardiovascular disease include translational technologies, prompt introduction of the latest scientific achievements and innovative methods in everyday clinical practice, a value-based approach and focus on patient needs, as well as coordinated patient care at the regional level based on the concept of risk management centres.
The participants of the online event discussed the existing limitations and opportunities to achieve the goals of the national Healthcare project in the control of cardiovascular disease, state support measures and treatment aspects for such diseases during the exacerbation of the epidemiological situation, and the social significance of the problem.